Searched for
FAVIPIRAVIR TABLETS
Bal Pharma stock hits upper circuit on affordable Favipiravir launchThe scrip hit upper circuit of 5 per cent to Rs 98.40 on Tuesday. The counter was settled at Rs 93.75 in the previous session. BSE Sensex w...- Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in IndiaFavipiravir is one of the leading oral anti-viral treatment approved in various countries for the potential treatment of patients with mild...
- Bajaj Healthcare launches generic favipiravir tablets for COVID-19 treatment"We hope the availability of an effective treatment such as Favijaj will considerably ease the pressure and offer patients much-needed and ...
- Dr Reddy's seeks approval from Health Canada for FavipiravirThe application was filed under Health Canada's "Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relatio...
- Gujarat: Demand for Remdesivir, oxygen falls as new cases decline"Cases of coronavirus in the state are declining and the demand and consumption of medical oxygen, Remdesivir injections and Favipiravir ta...
- After tablets, Hetero working on antiviral medicine Favipiravir injectionsIf successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...
- Favipiravir fastest molecule to cross Rs 100 crFavipiravir, a drug used in the treatment of Covid-19 patients with mild symptoms, became the largest-selling medicine in India in Septembe...
- Hetero launches pack of generic COVID-19 drug favipiravir at Rs 2,640"The launch of 'Favivir 800/200' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are re...
- BDR Pharma to launch 400mg Favipiravir tablets for treating coronavirus patients in IndiaThe company had received approval from the Drugs Controller General of India (DCGI) to manufacture Favipiravir to treat patients with mild ...
- Zenara Pharma receives DCGI approval to manufacture, sell Favipiravir tabletsZenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, announced that it has received approval from the Drugs Controlle...
- BDR Pharmaceuticals launches Favipiravir under brand name 'BDFAVI' at Rs 63 per tablet in IndiaBDR pharma has received an approval from the DCGI to manufacture Favipiravir to treat mild to moderate patients with COVID-19 symptoms. The...
- Lupin launches coronavirus drug Favipiravir in India at Rs 49 per tabletFavipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filin...
- Drug firms get DGCI nod for Covid drug favipiravir despite inconclusive studyOn Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...
- Glenmark Pharma cuts price of COVID-19 drug by 27% to Rs 75 per tabletIn a regulatory filing Glenmark announced a price reduction of 27 per cent for FabiFlu. The new maximum retail price (MRP) is Rs 75 per tab...
- Glenmark launches COVID-19 drug after DCGI nod; MRP at Rs 103 per tabletThe company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer p...
- Favipiravir and Remdesivir get approval for treatment“Under an accelerated approval process at the Central Drugs Standard Control Organisation (CDSCO), the Subject Expert Committee (SEC) has r...
- Glenmark launches Favipiravir: Medics say 'no magic bullet' for COVID but will help amid rising cases"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...
- Glenmark Pharma surges 35%, sees biggest intraday rise in history on Covid-19 drug launchThe firm launched antiviral drug Favipiravir for the treatment of Covid-19 patients.
- Glenmark pharma starts clinical trial on antiviral Favipiravir for Covid-19 treatmentThe drug sold under brand name Avigan by Fujifilm Toyama Chemical has demonstrated activity against influenza viruses and has been approved...
- Strides Pharma develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatmentStrides Pharma Science Ltd on Wednesday said it has developed and commercialised Favipiravir antiviral tablets and stressed that the drug h...
Load More
